In summary, intestinal permeability correlates with the severity of liver dysfunction, hyperlipidemia, liver fat deposition, insulin resistance, and intestinal barrier damage in patients with NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.